Overview:
Substantial business benefits are emerging from industry when Quality by Design (QbD) principles are used for new and existing drug products yielding reduced operating costs, enabling significantly more efficient manufacturing processes and better positioning companies to meet increasing regulatory expectations.
For example, the completion of ICH Guidelines, Q8 (R2): Pharmaceutical Development, Q9: Quality Risk Management and Q10: Pharmaceutical Quality System and the recent USFDA and Health Canada guidance’s on Process Validation contain recommendations for building and capturing process knowledge and understanding and establishing a strategy for process control during process design.
Why you should Attend:
Prepare participants to better understand the principles behind using QbD to develop a pharmaceutical product:
Areas Covered in the Session:
QbD principles discussed in this webinar include
Who Will Benefit:
Dr. Chaitanya Baliga has over 20 years of experience in quality management systems, regulatory compliance, and supplier management in industries, such as consumer products, medical device, pharmaceuticals, automotive, and toys. One of Chaitanya’s responsibilities is ensuring quality and compliance activities pertaining to manufacturing of regulated products (drugs, natural health products, cosmetics, and medical devices).